Structured page family:Cost guide

Triptorelin Cost Guide: Insurance, Cash Pay, and Savings

In the United States, Triptorelin costs depend on brand, pharmacy, insurance design, and whether the patient qualifies for manufacturer savings programs.

Active Market
This page is designed for US treatment decisions and uses US-first pricing and savings sources.
Official pricing
Verify current pricing directly on official Trelstar pages before starting, because list pricing, self-pay offers, and eligibility terms can change.
Cash-pay reality
Official cash-pay pricing varies by pharmacy and dose. Contact multiple pharmacies or use a prescription discount service for current rates.
Insurance coverage
Commercial coverage for Triptorelin varies by plan and indication. Prior authorization is commonly required.
Savings and coupons
Manufacturer savings programs may reduce out-of-pocket cost for eligible commercially insured patients.
Prior Authorization
Prior authorization is common and may require documentation of diagnosis, prior treatments, and clinical need.

Price Breakdown

List price (monthly)
~$1,500-$3,000/month depending on depot
Average wholesale price
~$1,400-$2,800/month
Pharmacy acquisition estimate
~$1,300-$2,500/month
Typical negotiated rate
~$1,000-$2,000/month
Price per dose
~$1,500 per 3.75 mg; ~$4,500 per 11.25 mg; ~$9,000 per 22.5 mg
Annual cost at list price
~$18,000-$36,000

Pharmacy Price Comparison

PharmacyPrice RangeNotes
Specialty pharmacy$1,400-$3,000/monthRequired
Hospital outpatientSimilar plus admin feeMay include injection fee

Insurance Coverage Landscape

Commercial plans
~90-95% for oncology/gynecology indications
Medicare Part D
Covered; may be Part B
Medicaid
Covered for approved indications
VA coverage
On formulary
TRICARE
Covered
Employer plan typical tier
Tier 3-4; copay $50-150 or coinsurance 20-30%

Prior Authorization Guide

Required Documentation
  • Prostate cancer: pathology, staging
  • Endometriosis: surgical/laparoscopic confirmation
  • Precocious puberty: bone age, LH/FSH
Common Denial Reasons
  • Off-label use
  • Insufficient staging documentation
  • Not prescribed by specialist
Appeal Template Points
  • FDA-approved indication
  • Pathology confirmed
  • Specialist-prescribed
  • Standard of care
Expected timeline: 3-5 days

Savings Programs and Patient Assistance

Manufacturer PAP
manufacturer
Eligibility: Uninsured, ≤400% FPL
Savings: Free or reduced
Income limit: ≤400% FPL
Enrollment: moderate
Annual application
Copay card
copay
Eligibility: Commercially insured
Savings: May reduce significantly
Income limit: None
Enrollment: simple
Annual cap

Generic and Biosimilar Status

No generic currently available
Expected: No generic depot expected soon

Cost by Dose

Dose/RegimenMonthlyAnnual
3.75 mg monthly$1,500$18,000
11.25 mg quarterly$1,500$18,000
22.5 mg semi-annual$1,500$18,000

Annual Cost Projection

Year 1
$1,200-$36,000
Year 2
$1,200-$36,000
Year 3
$1,200-$36,000
Assumptions
  • Ongoing therapy for prostate cancer
  • Interval affects total cost

Cost-Saving Strategies

  • 1.Choose longer depot intervals (3 or 6 months) to reduce injection and admin costs
  • 2.Apply for PAP if uninsured
  • 3.Ensure specialist prescription for smoother prior auth

International Price Comparison

CountryPrice RangeNotes
UK~£300-600/month (~$380-760)NHS

Need help comparing triptorelin paths?

Use the provider matcher to package treatment interest, insurance, budget, urgency, and state context before you commit to a prescribing path.

Find a triptorelin provider
Trust Summary
Reviewed 2026-04-27 by PeptideScholar editorial review. This page currently cites 2 official sources.
Pricing, savings eligibility, and coverage rules can change quickly. Verify all current figures and terms directly on official brand pages before acting.

Triptorelin Cost FAQ

Sources

  1. 1. Locally advanced and metastatic prostate cancer treated with intermittent androgen monotherapy or maximal androgen blockade: results from a randomised phase 3 study by the South European Uroncological Group.
    Eur Urol • 2014
    Claim type: clinical
    View source →
  2. 2. FDA Information on Triptorelin
    FDA • 2026
    Claim type: regulatory
    View source →

This content is for informational purposes only and does not constitute medical advice.